It is a pharma private limited company based in Raipur, Chattisgarh, India, established in 2020.
2020 | Raipur, Chattisgarh, India | ActiveAspire Pharmaceuticals Private Limited, a active private limited company, was established on 12 November 2020 in Raipur, Chattisgarh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24110CT2020PTC010922. Registered under ROC Roc Chhattisgarh. it is unlisted. It has an authorized capital of ₹11.70 Cr and a paid-up capital of ₹11.70 Cr.
It upholds a compliant status. Its leadership includes Naveen Deshlahara (Director), Rishabh Chopda (Director), Ashish Chopda (Director). Past directors included Anil Deshlahara, Naveen Deshlahara, Raunak Deshlahara. It holds ₹21.72 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.11, Kedia Business Park, Tatibandh,, Raipur, Chattisgarh, 492001.
U24110CT2020PTC010922
010922
12 November 2020
₹11.70 Cr
₹11.70 Cr
Roc Chhattisgarh
Unlisted
Active
Explore comprehensive insights into Aspire Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Deshlahara | Director | 01 Mar 2023 | Current |
| Rishabh Chopda | Director | 12 Nov 2020 | Current |
| Ashish Chopda | Director | 12 Nov 2020 | Current |
| Usha Sharma | Director | 01 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 05 Aug 2022 | Past |
| Pramod Abcsdd | Director | 05 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aspire Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Aspire Pharmaceuticals had a public holding of 39.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹217,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2025 | Sidbi | ₹1.72 Cr | Open |
| 22 Dec 2023 | Sidbi | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Aspire Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aspire Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Sidbi amounted to Rs. 1.72 Cr with Charge ID 101040740 was registered on 30 Jan 2025. was documented.
Progress on Aspire Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Aspire Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chhattisgarh. was documented.
A charge with Sidbi amounted to Rs. 20.00 Cr with Charge ID 100835264 was registered on 22 Dec 2023. was recorded as a recent event.
The activity Naveen Deshlahara was appointed as a Director was appointed as a Director on 01 Mar 2023 & has been associated with this company since 2 years 9 months . was completed.
Progress on Usha Sharma was appointed as a Director was appointed as a Director on 01 Mar 2023 & has been associated with this company since 2 years 9 months . was documented.
The CIN of Aspire Pharmaceuticals Private Limited is U24110CT2020PTC010922.
Aspire Pharmaceuticals Private Limited is headquartered at Plot No.11, Kedia Business Park, Tatibandh,, Raipur, Chattisgarh, 492001.
Aspire Pharmaceuticals Private Limited was incorporated on 12 November 2020.
The current directors of Aspire Pharmaceuticals Private Limited are
The primary industry of Aspire Pharmaceuticals Private Limited is Pharma.
Aspire Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aspire Pharmaceuticals Private Limited is ₹11.70 Cr, and the paid-up capital is ₹11.70 Cr.
The compliance status of Aspire Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX